Trademark: 79313411
Word
PHYTOMAB
Status Date
Tuesday, August 9, 2022
Registration Number
6810859
Registration Date
Tuesday, August 9, 2022
Filing Date
Tuesday, April 6, 2021
Published for Opposition
Tuesday, May 24, 2022
5 Medicines for the treatment of cancer, namely, anticancer medicines; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for treatment of cancer; proteins for medical, pharmaceutical and veterinary purposes, namely, protein arrays for medical diagnosis purposes; biological vectors for medical, pharmaceutical and veterinary purposes, namely, viral vectors for treatment of cancer; [ preparations of transformation microorganisms for medical, pharmaceutical and veterinary purposes, namely, for the treatment of cancer; preparations of microorganisms for medical, pharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; ] preparations of gene recombination for medical, pharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medical, pharmaceutical and veterinary purposes; cell lines for medical, pharmaceutical and veterinary purposes; medical, pharmaceutical and veterinary preparations for the treatment of cells; stem cells for medical, pharmaceutical and veterinary purposes; vaccines for medical, pharmaceutical and veterinary purposes; antibiotics for medical, pharmaceutical and veterinary purposes; anti-cancer preparations for medical, pharmaceutical and veterinary purposes; nucleic acid sequences for medical, pharmaceutical and veterinary purposes; biopharmaceuticals for treatment of hepatitis; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of auto-immune diseases
42 [ pharmaceutical research and development; ] chemistry services, namely, chemical analysis; synthetic biology services, namely, research and analysis in the field of synthetic biology; stem cells biology services, namely, research and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; [ laboratory research services relating to pharmaceuticals; ] testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medical, pharmacological and veterinary science; laboratory research in the field of pharmaceuticals, biology, biochemistry and chemistry; research and development services in the field of [ microorganisms and ] cells technology; research services in the field of chemistry, biochemistry, enzymology, biology, cell biology and biotechnology
The mark consists of the word "PHYTOMAB" colored blue. The figures of split leaf consist of right upper part gradated green to light green and left lower part gradated blue to light blue. The color white appears along the line of leaf veins.
In the statement, classes 5 and 42 have been corrected per the Restriction dated 01/26/2023 and the Fnote dated 05/03/2023.
The color(s) blue, green, light green, light blue, white is/are claimed as a feature of the mark.
Jan 13, 2024
Invalidation Reviewed - No Action Required By Office
Jan 3, 2024
Partial Invalidation Of Reg Ext Protection Created
Jun 8, 2023
New Representative At Ib Received
Jun 6, 2023
Notice Of Updated Registration Confirmation Emailed
May 3, 2023
Limitation From The Ib Examined And Entered
May 3, 2023
Correction Under Section 7 - Processed
Feb 6, 2023
Limitation Of Goods Received From Ib
Dec 12, 2022
Final Decision Transaction Processed By Ib
Nov 18, 2022
Final Disposition Notice Sent To Ib
Nov 18, 2022
Final Disposition Processed
Nov 9, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 9, 2022
Notice Of Registration Confirmation Emailed
Aug 9, 2022
Registered-Principal Register
May 24, 2022
Notification Processed By Ib
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Possible Opposition Sent To Ib
May 4, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 16, 2022
Approved For Pub - Principal Register
Apr 6, 2022
Teas/Email Correspondence Entered
Apr 6, 2022
Correspondence Received In Law Office
Apr 6, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 6, 2022
Teas Change Of Correspondence Received
Apr 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2022
Teas Change Of Owner Address Received
Apr 6, 2022
Teas Response To Office Action Received
Jan 15, 2022
Refusal Processed By Ib
Dec 27, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Dec 27, 2021
Refusal Processed By Mpu
Nov 30, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Nov 29, 2021
Non-Final Action Written
Nov 22, 2021
Assigned To Examiner
Jun 26, 2021
Application Filing Receipt Mailed
Jun 22, 2021
New Application Office Supplied Data Entered
Jun 17, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
